Drug Trial Radar · NCT02156674
Naglazyme After Allo Transplant for Maroteaux-Lamy Syndrome
Last checked: Nov 20, 2026Latest source record: Dec 23, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
1
Actual
Start
Jan 26, 2016
Primary completion
Dec 1, 2019
Study completion Dec 1, 2019
Sponsor
- Lead sponsor
- Masonic Cancer Center, University of MinnesotaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- BioMarin Pharmaceutical
- First posted
- Jun 5, 2014
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 3 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a single center study in which Naglazyme® will be given weekly for two years in patients with Maroteaux-Lamy syndrome, also known as mucopolysaccharide VI (MPS VI), who have previously been treated with an allogeneic transplant.
Conditions
- Maroteaux-Lamy Syndrome
Interventions
Naglazyme®Drug
1 mg per kg of body weight administered once weekly as an intravenous infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Urinary Glycosaminoglycan (GAG) ExcretionTime frame: Baseline and 2 years
- Change in Distance TraveledTime frame: Baseline and 2 years
- Change in Neurocognitive AbilityTime frame: Baseline and 2 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Minnesota Medical Center, Fairview
Minneapolis, Minnesota
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.